Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion
ConclusionThrombotic and bleeding complications related to NOACs were uncommon (<0.5%) in real life AF patients undergoing elective cardioversion.
Source: Europace - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Heart | Ischemic Stroke | Pradaxa | Stroke | Study | Vitamin K | Vitamins | Warfarin